These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8328786)
41. Trypanocidal activity of 2-propen-1-amine derivatives on trypomastigotes culture and in animal model. Oliveira DA; Pereira DG; Fernandes AM; De Castro SL; Souza Brito AR; De Souza AO; Durán N Parasitol Res; 2005 Feb; 95(3):161-6. PubMed ID: 15616861 [TBL] [Abstract][Full Text] [Related]
42. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes. Rangel H; Dagger F; Hernandez A; Liendo A; Urbina JA Antimicrob Agents Chemother; 1996 Dec; 40(12):2785-91. PubMed ID: 9124841 [TBL] [Abstract][Full Text] [Related]
43. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease. Urbina JA; Payares G; Sanoja C; Lira R; Romanha AJ Int J Antimicrob Agents; 2003 Jan; 21(1):27-38. PubMed ID: 12507835 [TBL] [Abstract][Full Text] [Related]
50. The antimycotic drug terbinafine in contrast to ketoconazole lacks acute effects on the pituitary-testicular function of healthy men: a placebo-controlled double-blind trial. Nashan D; Knuth UA; Weidinger G; Nieschlag E Acta Endocrinol (Copenh); 1989 May; 120(5):677-81. PubMed ID: 2499150 [TBL] [Abstract][Full Text] [Related]
51. Glutamine metabolism modulates azole susceptibility in Dumoulin PC; Vollrath J; Tomko SS; Wang JX; Burleigh B Elife; 2020 Dec; 9():. PubMed ID: 33258448 [TBL] [Abstract][Full Text] [Related]
53. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi. Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830 [TBL] [Abstract][Full Text] [Related]
54. Successful Aspects of the Coadministration of Sterol 14α-Demethylase Inhibitor VFV and Benznidazole in Experimental Mouse Models of Chagas Disease Caused by the Drug-Resistant Strain of Trypanosoma cruzi. Guedes-da-Silva FH; Batista DDGJ; Da Silva CF; Pavão BP; Batista MM; Moreira OC; Souza LRQ; Britto C; Rachakonda G; Villalta F; Lepesheva GI; Soeiro MNC ACS Infect Dis; 2019 Mar; 5(3):365-371. PubMed ID: 30625275 [TBL] [Abstract][Full Text] [Related]
55. The efficacy of an N-substituted imidazole, RS-49676, against a Trypanosoma cruzi infection in mice. Scott VR; Matthews TR Am J Trop Med Hyg; 1987 Sep; 37(2):308-13. PubMed ID: 3116868 [TBL] [Abstract][Full Text] [Related]
56. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Ryder NS Br J Dermatol; 1992 Feb; 126 Suppl 39():2-7. PubMed ID: 1543672 [TBL] [Abstract][Full Text] [Related]
57. In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi. Liendo A; Lazardi K; Urbina JA J Antimicrob Chemother; 1998 Feb; 41(2):197-205. PubMed ID: 9533461 [TBL] [Abstract][Full Text] [Related]
58. Efficacy of the bisbenzylisoquinoline alkaloids in acute and chronic Trypanosoma cruzi murine model. Fournet A; Rojas de Arias A; Ferreira ME; Nakayama H; Torres de Ortiz S; Schinini A; Samudio M; Vera de Bilbao N; Lavault M; Bonté F Int J Antimicrob Agents; 2000 Jan; 13(3):189-95. PubMed ID: 10724023 [TBL] [Abstract][Full Text] [Related]
59. Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection of mice against lethal infection with the organism. McCabe RE; Remington JS; Araujo FG J Infect Dis; 1984 Oct; 150(4):594-601. PubMed ID: 6092485 [TBL] [Abstract][Full Text] [Related]